Category: Press Releases

EQS-News: Epigenomics AG / Key word(s): Half Year Report/Half Year ResultsEpigenomics AG publishes financial results for the first six months 2023 10.08.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG publishes financial results for the first six months 2023 Berlin (Germany), August 10, 2023 – Epigenomics AG (FSE: […]

EQS-News: Epigenomics AG / Key word(s): Strategic Company Decision/ContractEpigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets 24.07.2023 / 18:40 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets Acquirer is U.S. full-service diagnostics and CRO services company New Day […]

EQS-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter Results​​​​​​​Epigenomics AG Reports Financial Results for the First Quarter of 2023 31.05.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Financial Results for the First Quarter of 2023 Berlin (Germany) and San Diego, CA (USA), May 31, […]

EQS-News: Epigenomics AG / Key word(s): Personnel/MiscellaneousEpigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns 19.05.2023 / 18:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns  Berlin (Germany), May 19, 2023 -The Member […]

EQS-News: Epigenomics AG / Key word(s): Annual Results/Annual Report​​​​​​​Epigenomics AG publishes financial results for fiscal year 2022 28.04.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG publishes financial results for fiscal year 2022 Berlin (Germany) and San Diego, CA (U.S.A.), April 28, 2023 – Epigenomics AG (FSE: ECX, […]

EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Chief Executive Officer Greg Hamilton Resigns 12.04.2023 / 20:05 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Chief Executive Officer Greg Hamilton Resigns Berlin (Germany), April 12, 2023 – The Chief Executive Officer of Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; […]